Research Points a Way to Modulate Scarring in Spinal Cord Injury
David Julius and Wendy Yue have discovered a natural mechanism that could help reduce scarring after a spinal cord injury.
University of California San Francisco
Give to UCSFDavid Julius and Wendy Yue have discovered a natural mechanism that could help reduce scarring after a spinal cord injury.
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.
A new video-based symptom assessment system for Parkinson’s Disease that is enabled by machine learning represents a potential solution to the challenge of assessing Parkinson’s Disease progression in a quantifiable way.
Scientists at UCSF and Contineum Therapeutics have developed a drug that spurs the body to replace the protective insulation around nerve cells, myelin, that is lost in multiple sclerosis. If it works in people, it could be a way to reverse the damage caused by the disease.
A team of epilepsy specialists at UC San Francisco has developed a method to predict 24-hour seizure risk. The discovery, which may be scalable to large numbers of patients, could help to improve the
A newly discovered hormone explains why females can maintain bone density during lactation, when calcium is stripped away to make milk. This discovery could one day have applications to treating fractures, osteoporosis, and other bone diseases.
Despite recent advancements in the treatment of Parkinson’s Disease, it remains a challenge to accurately measure the progression of symptoms like tremors, stiffness and slowing of movement for this
Scientists have identified the biomarkers in progressive supranuclear palsy, a type of frontotemporal dementia, the most common dementia affecting people under 60.
A study linked chronic inflammation in early adulthood to loss of cognitive skills in midlife. Chronic inflammation is caused by obesity, smoking, and poor health. Those with higher levels of inflammation were twice as likely to have poor cognitive performance than those with low inflammation.
Three UC San Francisco scientists have received 2024 Pew awards to fund their research in neuroscience and cancer: cognitive scientist Vijay Mohan K Namboodiri, PhD; bioengineer Justin Eyquem, PhD; and postodctoral student Jovanka Gencel-Augusto, PhD.
UCSF scientists made international headlines when they developed a brain-computer interface that allowed a stroke survivor to speak for the first time in 18 years. Find this award-winning video, which has been viewed by millions, on UCSF’s YouTube channel.
A generation ago, a diagnosis of multiple sclerosis was a guarantee of a debilitating disease that would leave the patient wheelchair bound, and worse. Follow UCSF’s role in what some call the golden age of MS research and care.
Traumatic brain injuries for people over age 65 can raise their risk for dementia, Parkinson's, cardiovascular and psych disease. Contrary to earlier research, the study found that healthy, wealthy white women are at higher risk.
The disabling effects of multiple sclerosis may be caused in part by damaged connections between neurons, and this can be seen in the eye, UC San Francisco researchers have found. They showed that
Transcranial magnetic stimulation (TMS) is a noninvasive in-office procedure. Brief magnetic pulses to the brain induces electrical currents that stimulate nerve cells in specific areas of the brain, providing symptom relief for patients with depression and OCD.
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
When a mouthful of water goes down the wrong pipe – heading toward a healthy person’s lungs instead of their gut – they start coughing uncontrollably. That’s because their upper airway senses the
Mild brain inflammation destroys arm-like projections of neurons rather than the neurons themselves, but can still cause significant brain damage.
UCSF scientists have been awarded more than $30 million to develop “tissue GPS,” a new system using engineered T cells to guide therapies directly to their targets in the brain to treat neurological diseases like cancer, multiple sclerosis and Alzheimer’s.
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in mid-life.
People with dementia and those who care for them should be screened for loneliness, so providers can find ways to keep them socially connected.
The Allen Institute is the newest member of the Weill Neurohub, a collaborative research network advancing treatments for neurological diseases.
Researchers recently identified a universal, essential biomarker for the childhood cancer neuroblastoma – and the biomarker could be a potential new target for treatment. Neuroblastoma accounts for
UCSF scientists may have discovered a new way to test for autism by measuring how children’s eyes move when they turn their heads.
Rather than simply hearing a string of notes, the brain is assessing them for patterns and predicting which notes will be next.
People with depression have higher body temperatures, suggesting there could be a mental health benefit to lowering the temperatures of those with depression.